AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Tofacitinib in Nigeria
1 product registered with NAFDAC — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Xeljanz 5 mg Tablets** Tablet | B4-7139 | Pfizer Specialties Ltd | active | 25 Jan 2028 |
Tofacitinib — NAFDAC Registration Details
NAFDAC (Nigeria) has 1 registered product containing Tofacitinib, of which 1 is currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Tofacitinib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.